Discover 1,378 paid clinical trials in St. Louis, Missouri. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
St. Louis currently offers medical research opportunities for a variety of conditions, including cancer, heart disease, prurigo nodularis, and pain management. The city's leading institutions are actively recruiting participants, offering opportunities for healthy volunteers in paid studies, as well as those seeking trials for specific health conditions, providing access to innovative treatments and advanced medical care.
Filter
2
Filter results
Results: 1,378
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
for
Clostridoides Difficile Associated Disease
Location: St Louis MO, Memphis TN, Nashville TN, Melrose Park IL,
Sponsor: Pfizer
Sex: All
Age: 65+
Code: NCT07282665
Phase3, Recruiting
INCLUDE Program: A Perioperative Wellness Program Tailored for Black Surgical Patients
for
Surgery
Location: St Louis MO
Sponsor: Washington University School of Medicine
Sex: All
Age: 60+
Code: NCT07283783
Recruiting
An AI-Generated, Personalized Question Prompt List Intervention for Patients With Hematologic Cancers
for
Lymphoma, Multiple Myeloma
Location: St Louis MO
Sponsor: Washington University School of Medicine
Sex: All
Age: 18 - 70+
Code: NCT07226934
Recruiting
A Study of the Drug Letermovir as Prevention of Cytomegalovirus Infection After Stem Cell Transplant in Pediatric Patients
for
Hematopoietic and Lymphoid Cell Neoplasm,
Location: St Louis MO, Iowa City IA, Indianapolis IN,
Sponsor: Children's Oncology Group
Sex: All
Age: 2 - 18
Code: NCT05711667
Phase3, Recruiting
A Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
for
Multiple Sclerosis (MS) Primary Progressive
Location: St Louis MO, Cordova TN, Roeland Park KS, Milwaukee WI,
Sponsor: Zenas BioPharma (USA), LLC
Sex: All
Age: 18 - 60
Code: NCT07067463
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Whole Genome Sequencing (ChromoSeq) as an Adjunct to Conventional Genomic Profiling in MDS
A Study of Amivantamab in Addition to Standard of Care Agents (SOC) Compared With SOC Alone in Participants With Recurrent/Metastatic Head and Neck Cancer
for
Squamous Cell Carcinoma of Head and Neck
Location: St Louis MO, O'Fallon IL, Nashville TN, Chicago IL,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07276399
Phase3, Recruiting
The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms
Location: St Louis MO, Iowa City IA, Nashville TN, Chicago IL,
Sponsor: phenox Inc.
Sex: All
Age: 18+
Code: NCT07143019
Recruiting
Study to Assess the Efficacy and Safety of Rina-S Compared to Treatment of Investigator's Choice in Participants With Endometrial Cancer
for
Endometrial Cancer, Recurrent or Progressive Endometrial Cancer
Location: St Louis MO, Evanston IL, Cincinnati OH,
Sponsor: Genmab
Sex: Female
Age: 18+
Code: NCT07166094
Phase3, Recruiting
Safety and Efficacy of BNT327, an Investigational Therapy in Combination With Chemotherapy for Patients With Untreated Small-cell Lung Cancer
for
Extensive-stage Small-cell Lung Cancer
Location: St Louis MO, Elizabethtown KY, Germantown TN,
Sponsor: BioNTech SE
Sex: All
Age: 18+
Code: NCT06712355
Phase3, Recruiting
CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma
for
Diffuse Midline Glioma, H3 K27-Altered,
Location: St Louis MO, Indianapolis IN, Kansas City MO,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 21
Code: NCT04870944
Phase1, Phase2, Recruiting
Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
for
Non-Small Cell Lung Cancer
Location: St Louis MO, Nashville TN, Chicago IL, Columbus OH,
Sponsor: Bristol-Myers Squibb
Sex: All
Age: 18+
Code: NCT07100080
Phase2, Phase3, Recruiting
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
for
Uterine Cancer, Rectal Cancer, Colon Cancer, Breast Cancer,
Location: St Louis MO
Sponsor: Washington University School of Medicine
Sex: Female
Age: 18 - 50
Code: NCT06904365
Recruiting
Role of the Gut Microbiome in Complex Regional Pain Syndrome
for
Complex Regional Pain Syndromes
Location: St Louis MO
Sponsor: Washington University School of Medicine
Sex: All
Age: 18+
Code: NCT03612193
Recruiting
Neoadjuvant Zanzalintinib Plus Nivolumab in Patients With Locally Advanced and/or Inoperable Clear Cell Renal Cell Carcinoma With or Without Non-measurable Metastasis
for
Locally Advanced Renal Cell Carcinoma
Location: St Louis MO, Dallas TX, Richmond VA
Sponsor: Qian Qin
Sex: All
Age: 18+
Code: NCT06794229
Phase2, Recruiting
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
for
Ovarian Neoplasms, Breast Neoplasms,
Location: St Louis MO, Indianapolis IN, Madison WI,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07213791
Phase1, Recruiting
A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: St Louis MO, Westwood KS, Nashville TN, Chicago IL,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT06973187
Phase3, Recruiting
Transcutaneous Auricular Vagus Enhanced Recovery in the NeuroICU
for
Acute Neurological Injury, Acute Medical Conditions
Location: St Louis MO
Sponsor: Washington University School of Medicine
Sex: All
Age: 18+
Code: NCT07219108
Recruiting
CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
for
Transthyretin Amyloid Cardiomyopathy (ATTR CM)
Location: St Louis MO, Indianapolis IN, Kansas City MO,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07207811
Phase3, Recruiting
Zanzalintinib Combined With Eribulin in Advanced Liposarcoma and Leiomyosarcoma